SEC Form 4 · accession 0000884731-16-000107
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Bollag
Officer — Sr. VP, Reg. Affairs & Quality
Period of report
Sep 26, 2016
Accepted (ET)
Sep 28, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 26, 2016 | M | 10,000 | $0.00 | A | 176,788 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance stock unitF2,F3 | — | Sep 26, 2016 | M | 10,000 | D | — | — | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
- F2Each performance stock unit represents a right to receive done share of ARIAD common stock
- F3The performance stock units vest as to 50% of the award on 9/24/15 and 50% of the award on 9/26/2016.